Benzhydrocodone

Drug Profile

Benzhydrocodone

Alternative Names: KP-201; KP201/IR (acetaminophen-free); KP201/IR (APAP-free)

Latest Information Update: 15 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator KemPharm
  • Class Benzoates; Epoxy compounds; Morphinans; Opioid analgesics; Small molecules
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Acute pain

Most Recent Events

  • 20 Dec 2016 Benzhydrocodone receives Fast Track designation for Acute pain [Intranasal] in USA
  • 29 Nov 2016 US FDA accepts IND application for benzhydrocodone (KP 201/IR) in Acute pain
  • 25 Oct 2016 KemPharm files an IND application with the FDA in USA for Acute pain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top